OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer
Xingyu Chen, Lixiang Feng, Yujing Huang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 37
Xingyu Chen, Lixiang Feng, Yujing Huang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
Zhen Yang, Xinpeng Liu, Jun Zhu, et al.
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 86-102.e10
Closed Access | Times Cited: 1
Zhen Yang, Xinpeng Liu, Jun Zhu, et al.
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 86-102.e10
Closed Access | Times Cited: 1
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
Gianluca Santamaria, Mario Cioce, Antonia Rizzuto, et al.
Cancer Drug Resistance (2023), pp. 447-67
Open Access | Times Cited: 2
Gianluca Santamaria, Mario Cioce, Antonia Rizzuto, et al.
Cancer Drug Resistance (2023), pp. 447-67
Open Access | Times Cited: 2
Lipidic and senescent macrophages predict progression and response to combinatorial immunotherapy in triple-negative breast cancer
C. Chan, Alex To, Shihui Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
C. Chan, Alex To, Shihui Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhancing the Efficacy of Breast Cancer Immunotherapy Using a Smac-Armed Oncolytic Virus
Sijia Tang, Kristin V. Lyles, Yuzhen Wang, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3248-3248
Open Access
Sijia Tang, Kristin V. Lyles, Yuzhen Wang, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3248-3248
Open Access
Vibrational, theoretical characterisation and In Silico investigation of Norcinnamolaurine: a natural lead for inhibiting AURKA and overcoming immune evasion in Triple-Negative Breast Cancer
P. Sangavi, S. Muthu, J.N. Cheerlin Mishma, et al.
Molecular Simulation (2024) Vol. 50, Iss. 17-18, pp. 1614-1630
Closed Access
P. Sangavi, S. Muthu, J.N. Cheerlin Mishma, et al.
Molecular Simulation (2024) Vol. 50, Iss. 17-18, pp. 1614-1630
Closed Access
First-line immunotherapy efficacy in advanced squamous non-small cell lung cancer with PD-L1 expression ≥50%: a network meta-analysis of randomized controlled trials
Wei Chen, Hangmei Liu, Yiwen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Wei Chen, Hangmei Liu, Yiwen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, et al.
Clinical & Translational Oncology (2024)
Closed Access
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, et al.
Clinical & Translational Oncology (2024)
Closed Access
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Overexpressed CFLAR drives 5-fluorouracil sensitivity and immune response in breast cancer by regulating reactive oxygen species
Chunjiang Wang, Jiaqing He, Xiaopei Tong, et al.
Research Square (Research Square) (2023)
Open Access
Chunjiang Wang, Jiaqing He, Xiaopei Tong, et al.
Research Square (Research Square) (2023)
Open Access
Vaginal metastasis from breast cancer: A case report
Yunbo Yan, Tianjiao Guo, M J Zhang, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access
Yunbo Yan, Tianjiao Guo, M J Zhang, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access
Editorial: Global excellence in translational immunology: Europe
Federica Casiraghi, Norberto Perico, Giuseppe Remuzzi
Frontiers in Immunology (2023) Vol. 14
Open Access
Federica Casiraghi, Norberto Perico, Giuseppe Remuzzi
Frontiers in Immunology (2023) Vol. 14
Open Access
FAM83H Expression Is Associated with Tumor-Infiltrating PD1-Positive Lymphocytes and Predicts the Survival of Breast Carcinoma Patients
Ji Eun Choi, Ae Ri Ahn, Junyue Zhang, et al.
Diagnostics (2023) Vol. 13, Iss. 18, pp. 2959-2959
Open Access
Ji Eun Choi, Ae Ri Ahn, Junyue Zhang, et al.
Diagnostics (2023) Vol. 13, Iss. 18, pp. 2959-2959
Open Access
Advancing Immunotherapy in Triple Negative Breast Cancer: A Novel Multimodal Theranostic Nanoplatform Integrating Synergetic Ferroptosis and Photothermal Therapy
Long Cheng, Yi‐Bo Qiu, Ling‐Yun He, et al.
(2023)
Closed Access
Long Cheng, Yi‐Bo Qiu, Ling‐Yun He, et al.
(2023)
Closed Access
